FDA Inspection 1030585 — HCSC Blood Center
The FDA completed an inspection of HCSC Blood Center on October 19, 2017 in Reading, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 19, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Reading, PA (United States)